Washington Trust’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-33
Closed -$2.35K 272
2025
Q1
$2.35K Sell
33
-152
-82% -$12.4K ﹤0.01% 717
2024
Q4
$16K Buy
185
+2
+1% +$199 ﹤0.01% 616
2024
Q3
$17.4K Hold
183
﹤0.01% 608
2024
Q2
$17.5K Buy
183
+5
+3% +$595 ﹤0.01% 598
2024
Q1
$23.5K Sell
178
-8
-4% -$985 ﹤0.01% 554
2023
Q4
$26.9K Buy
186
+29
+18% +$3.98K ﹤0.01% 515
2023
Q3
$26.7K Hold
157
﹤0.01% 490
2023
Q2
$35K Hold
157
﹤0.01% 469
2023
Q1
$34.7K Hold
157
﹤0.01% 471
2022
Q4
$34K Hold
157
﹤0.01% 464
2022
Q3
$42K Sell
157
-50
-24% -$12.7K ﹤0.01% 418
2022
Q2
$43K Hold
207
﹤0.01% 429
2022
Q1
$46K Hold
207
﹤0.01% 441
2021
Q4
$48K Sell
207
-370
-64% -$91.6K ﹤0.01% 446
2021
Q3
$126K Buy
577
+57
+11% +$12.2K ﹤0.01% 370
2021
Q2
$87K Hold
520
﹤0.01% 427
2021
Q1
$76K Sell
520
-33
-6% -$5.3K ﹤0.01% 432
2020
Q4
$81K Buy
553
+143
+35% +$17K ﹤0.01% 406
2020
Q3
$37K Buy
+410
New +$36.3K ﹤0.01% 500

Other funds holding ALB

Washington Trust's ALB Position: Q2 2025 in Review

Washington Trust sold out of Albemarle (ALB) in Q2 2025, closing a stake of 33 shares — an estimated $2.35K sold.

Washington Trust first reported a position in ALB in Q3 2020 and held it in 19 quarters. The position peaked at $126K in Q3 2021. 698 funds tracked by Wall St. Rank hold ALB as of Q2 2025.

  • Washington Trust reported no remaining Albemarle position as of Q2 2025 after selling out during the quarter.
  • Washington Trust sold 33 Albemarle shares in Q2 2025, an estimated $2.35K.
  • Washington Trust first reported a position in Albemarle in Q3 2020 and held it in 19 quarters.
  • Washington Trust's Albemarle position peaked at $126K in Q3 2021.
  • 698 funds tracked by Wall St. Rank held Albemarle as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.